Literature DB >> 26194883

Contrasting effects of G1.2/G2.2 and SOF1/SOF2 embryo culture media on pre- and post-implantation development of non-transgenic and transgenic cloned goat embryos.

Sayed Morteza Hosseini1, Mehdi Hajian1, Somayyeh Ostadhosseini1, Mohsen Forouzanfar1, Parvaneh Abedi1, Farnoosh Jafarpour1, Hamid Gourabi2, Abdol Hossein Shahverdi3, Ahmad Vosough4, Hamid Reza Ghanaie1, Mohammad Hossein Nasr-Esfahani5.   

Abstract

This study compared the efficiency of two embryo culture media (SOF1/SOF2 and G1.2/G2.2) for pre- and post-implantation development of somatic cell nuclear transfer goat embryos derived from non-transgenic and transgenic (for htPA and hrcfIX genes) fibroblasts. Despite similar cleavage rates, G1.2/G2.2 supported significantly higher blastocyst development than SOF1/SOF2 (30-35% versus 21%; P < 0.05), irrespective of cell transgenesis. However, following embryo transfer, pregnancy outcomes (establishment, full-term development and live birth) were all significantly higher (P < 0.05) for embryos developed in SOF1/SOF2 versus G1.2/G2.2. Gene expression profiling of 17 developmentally important genes revealed that: (i) SOX2, FOXD3, IFNT, FZD, FGFR4, ERK1, GCN5, PCAF, BMPR1, SMAD5, ALK4, CDC25 and LIFR were significantly induced in blastocysts developed in SOF1/SOF2 but not G1.2/G2.2; (ii) OCT4, CTNNB and CDX2 were similarly expressed in both groups; and (iii) AKT was significantly higher in G1.2/G2.2 than SOF1/SOF2 (P < 0.05). Following IVF, although blastocyst development in G1.2/G2.2 was significantly higher than SOF1/SOF2 counterparts, the majority of assessed genes were similarly expressed in blastocysts developed in both groups. It was concluded that the long-term programming effects of embryo culture medium and/or embryo production method may irreversibly affect post-implantation development of cloned embryos through defined molecular pathways.
Copyright © 2015 Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  G1.2/G2.2; SOF1/SOF2; embryo development; gene expression; goat; nuclear transfer

Mesh:

Substances:

Year:  2015        PMID: 26194883     DOI: 10.1016/j.rbmo.2015.06.008

Source DB:  PubMed          Journal:  Reprod Biomed Online        ISSN: 1472-6483            Impact factor:   3.828


  6 in total

1.  Dynamics of The Expression of Pluripotency and Lineage Specific Genes in The Pre and Peri-Implantation Goat Embryo.

Authors:  Pouria HosseinNia; Mehdi Hajian; Farnoosh Jafarpour; Seyed Morteza Hosseini; Mojtaba Tahmoorespur; Mohammad Hossein Nasr-Esfahani
Journal:  Cell J       Date:  2019-02-20       Impact factor: 2.479

Review 2.  Epigenetic manipulation to improve mouse SCNT embryonic development.

Authors:  Yamei Li; Qiang Sun
Journal:  Front Genet       Date:  2022-08-30       Impact factor: 4.772

3.  Expression Profile of Developmentally Important Genes in preand peri-Implantation Goat Embryos Produced In Vitro.

Authors:  Pouria HosseinNia; Mehdi Hajian; Mojtaba Tahmoorespur; Sayyed Morteza Hosseini; Somayyeh Ostadhosseini; Mohammad Reza Nasiri; Mohammad Hossein Nasr-Esfahani
Journal:  Int J Fertil Steril       Date:  2016-09-05

Review 4.  Choosing a culture medium for SCNT and iSCNT reconstructed embryos: from domestic to wildlife species.

Authors:  A Cordova; W A King; G F Mastromonaco
Journal:  J Anim Sci Technol       Date:  2017-11-10

5.  Comparative Stepwise Pattern of Reactive Oxygen Species Production during In Vitro Development of Fertilized and Nuclear Transferred Goat Embryos.

Authors:  Mehdi Hajian; Sayed Morteza Hosseini; Somayyeh Ostadhosseini; Mohammad Hossein Nasr-Esfahani
Journal:  Int J Fertil Steril       Date:  2017-02-16

6.  The Impact of Two Embryo Culture Media, Synthetic Oviduct Fluid and Commercial BO, on pre-and post-Implantation Development of Cloned SAANEN Goat Embryos.

Authors:  Mehdi Hajian; Farnoosh Jafarpour; Sayed Morteza Aghamiri; S Hiva Rouhollahi Varnosfaderani; Mohsen Rahimi Andani; Mohammad Hossein Nasr-Esfahani
Journal:  Int J Fertil Steril       Date:  2022-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.